iconEarnings Announcement Before Market Open

Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:57 PM EST
150.44quote price arrow up+5.65 (+3.91%)
Volume
11,665,759
52 week range
19.31 - 189.26

...

Loading . . .

KEY STATS

  • Open150.78
  • Day High160.98
  • Day Low146.40
  • Prev Close144.79
  • 52 Week High189.26
  • 52 Week High Date02/08/21
  • 52 Week Low19.31
  • 52 Week Low Date03/13/20
  • Market Cap59.532B
  • Shares Out395.71M
  • 10 Day Average Volume7.97M
  • Dividend-
  • Dividend Yield-
  • Beta1.53
  • 1 Year % Change537.25

RATIOS/PROFITABILITY

  • EPS (TTM)-1.62
  • P/E (TTM)-92.95
  • Fwd P/E (NTM)14.95
  • EBITDA (MRQ)-584.716M
  • ROE (MRQ)-29.80%
  • Revenue (MRQ)246.71M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-242.27%
  • Debt To Equity (MRQ)3.94%

EVENTS

  • Earnings Date02/25/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

QUOTE FINDER

Related Video

VIDEO2:1602:16
FDA finds J&J vaccine 'safe' and 'effective'

Profile

MORE
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States